Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Exemestane Plus Goserelin in Treating Premenopausal Women With Metastatic Breast Cancer

This study has been completed.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
New York University School of Medicine Identifier:
First received: February 2, 2001
Last updated: March 10, 2016
Last verified: March 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: May 2001 (Final data collection date for primary outcome measure)